Evidence map›Paper›PMID 33168604›Full record

ArticleAntimicrobial agents and chemotherapy2021

Continued Low Efficacy of Artemether-Lumefantrine in Angola in 2019.

Pedro Rafael Dimbu, Roberta Horth, Ana Luísa M Cândido, Carolina Miguel Ferreira, Felismina Caquece, Luzala Elisabeth Armando Garcia, Kialanda André, Garcia Pembele, Domingos Jandondo, Belmira José Bondo and 12 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 3 pooled it
8.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 3 syntheses or guidelines pooled it, 72 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Single-cell transcriptional changes of artemisinin-sensitive K13Frontiers in cellular and infection microbiology · 2026
    Article
  13. Mapping the prevalence of molecular markers ofmedRxiv : the preprint server for health sciences · 2025
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Geo-classification of drug-resistant travel-associatedAntimicrobial agents and chemotherapy · 2024
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors at 3 institutions in 3 countries.

Pedro Rafael DimbuNational Malaria Control Program, Ministry of Health, Luanda, Angola.
Roberta HorthEpidemic Intelligence Service, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Ana Luísa M CândidoNational Institute of Health Research, Ministry of Health, Luanda, Angola.
Carolina Miguel FerreiraPopulation Services International Angola, Luanda, Angola.
Felismina CaqueceField Epidemiology Training Program, Ministry of Health, Luanda, Angola.
Luzala Elisabeth Armando GarciaField Epidemiology Training Program, Ministry of Health, Luanda, Angola.
Kialanda AndréField Epidemiology Training Program, Ministry of Health, Luanda, Angola.
Garcia PembeleNational Institute of Health Research, Ministry of Health, Luanda, Angola.
Domingos JandondoNational Institute of Health Research, Ministry of Health, Luanda, Angola.
Belmira José BondoNational Malaria Control Program, Ministry of Health, Luanda, Angola.
Benjamin Nieto AndradePopulation Services International Angola, Luanda, Angola.
Sarah LabudaMalaria Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Gabriel Ponce de LeónMalaria Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Julia KelleyMalaria Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Dhruviben PatelMalaria Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Samaly S SvigelMalaria Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Eldin TalundzicMalaria Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Naomi LucchiMalaria Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Joana F M MoraisNational Institute of Health Research, Ministry of Health, Luanda, Angola.
Filomeno FortesInstitute of Hygiene and Tropical Medicine, Nova University of Lisbon, Lisbon, Portugal.
José Franco MartinsNational Malaria Control Program, Ministry of Health, Luanda, Angola.
Mateusz M PlucińskiMalaria Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA mplucinski@cdc.gov.ORCID 0000-0002-7322-4625
Ministry of Health · AOCenters for Disease Control and Prevention · USUniversity of Lisbon · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biennial therapeutic efficacy monitoring is a crucial activity for ensuring the efficacy of currently used artemisinin-based combination therapy in Angola. Children with acute uncomplicated

Indexed as

AntimalarialsMalaria, FalciparumAmodiaquineAngolaArtemetherArtemether, Lumefantrine Drug CombinationChildDemocratic Republic of the CongoDrug CombinationsEthanolaminesHumansInfantPlasmodium falciparumAmodiaquineAntimalarialsArtemetherArtemether, Lumefantrine Drug CombinationDrug CombinationsEthanolaminesmalariamolecular markersresistance

Identifiers

PMID33168604
PMCPMC7849008
OpenAlexW3097818497

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.